EBS vs MSFT: Which is Better to Buy in 2026?

Side-by-side fundamental comparison based on AI analysis of SEC filings

AI Verdict

MSFT has stronger fundamentals based on our AI analysis.

EBS
Emergent BioSolutions Inc.
BUY
72%
Confidence
VS
MSFT
MICROSOFT CORP
BUY
91%
Confidence

EBS vs MSFT Fundamental Comparison

Metric EBS MSFT
Revenue $742.9M $158.9B
Net Income $52.6M $66.2B
Net Margin 7.1% 41.7%
ROE 10.1% 16.9%
ROA 4.0% 10.0%
Current Ratio 5.01x 1.39x
Debt/Equity 1.13x 0.10x
EPS $0.93 $8.87

Green = Better metric | Red = Weaker metric

View Full EBS Analysis →
View Full MSFT Analysis →

You Might Also Compare

EBS vs AAPL MSFT vs GOOGL EBS vs AMZN MSFT vs NVDA

EBS vs MSFT: Frequently Asked Questions

Is EBS or MSFT a better buy in 2026?

Based on dual AI fundamental analysis (Claude and ChatGPT), MSFT has stronger fundamentals. EBS is rated BUY (72% confidence) while MSFT is rated BUY (91% confidence). This is not investment advice.

How does EBS compare to MSFT fundamentally?

Emergent BioSolutions Inc. has ROE of 10.1% vs MICROSOFT CORP's 16.9%. Net margins are 7.1% vs 41.7% respectively.

Which stock pays higher dividends, EBS or MSFT?

EBS has a dividend yield of N/A or no dividend while MSFT has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.

Should I invest in EBS or MSFT for long term?

For long-term investing, consider that EBS has BUY rating with 72% confidence, while MSFT has BUY rating with 91% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.

What do the AI models say about EBS vs MSFT?

Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For EBS vs MSFT, the AI consensus favors MSFT based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.